NovaBay Pharmaceuticals, Inc. / Stablecoin Development Corporation — Cyborg Score 4/10
Mixed
Blockchain and Cryptocurrencies
Strategic Profile
Following a $134 million private placement in January 2026, NovaBay completed its pivot to crypto, building a large position in SKY tokens and holding around 2.06 billion tokens. The firm has begun staking its SKY holdings to earn rewards, reporting around 26.6 million SKY tokens earned to date. The company transitioned from a struggling pharmaceutical/wound-care business to a digital asset holding company focused on stablecoin infrastructure.
Cyborg Score Rationale
The company executed a dramatic strategic pivot with significant fresh capital ($134M in January 2026) and credible entry into the stablecoin ecosystem at scale. However, this represents extreme business model transformation with no prior crypto operating experience, substantial execution risk, and historically poor shareholder returns prior to the crypto pivot.
Top Insights
(March 2026) Complete pivot from pharmaceuticals to stablecoin infrastructure; renamed to Stablecoin Development Corporation (SDEV)
(January 2026) Raised $134 million in private placement to fund entry into Sky protocol ecosystem
(October 2025) Regained NYSE American compliance after stockholders' equity fell below $6 million minimum
Historical core business (Avenova eye care, wound care) asset-light; prior struggles with consumer skincare (DERMAdoctor divested in 2024)
Named Competitors
Grayscale Bitcoin Trust — Crypto asset holding company
Microstrategy — Bitcoin accumulation and corporate treasury strategy
Sky Protocol — Stablecoin and DeFi protocol infrastructure
Recent Developments
(March 2026) Official name change to Stablecoin Development Corporation; ticker changed to SDEV on April 3, 2026
(January 2026) Completed $134 million private placement to acquire SKY tokens
(April 2026) Stock trading under new ticker SDEV on NYSE American
(October 2025) Regained NYSE American continued listing compliance
Open the full interactive NovaBay Pharmaceuticals, Inc. / Stablecoin Development Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.